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Respected Editor,
I read with attention your latest editorial recently published in 
the Brazilian Journal of Cardiovascular Surgery (BJCVS) regarding 
the publication of case reports[1]. This is a timely, accurate and 
concise editorial, addressing a topic of interest. Yes, it is true that 
case reports (CR) have been banned from many publications in 
recent years due to the reasons you have clearly alluded to. I have 
to support what it is in this editorial. As we need metrics, you 
produced actual data taken from the three most internationally 
important journals in our field and it is clear to the readership 
that CR still represents a proportion of what these journals, like 
the BJCVS, have also published. We have also seen this in many 
other publications. Some reasons may be the same; in some 
cases, journals may need more CR load. There may always be a 
reason for a CR with educational value.
Other journals have designed a different strategy. The 
good example is that of the Journal of the American College of 
Cardiology (JACC). The JACC, like other journals, have evolved in 
a way that a family of journals has been created. As per the JACC, 
the Journal of the American College of Cardiology-Case Reports 
has been launched in June 2019[2]. The JACC-CR focuses only 
on CR. The journal name is self-explanatory. After a peer-review 
process, accepted cases are published under the formula which 
contemplates publication fees. Moreover, this tendency goes on 
around the world.
Therefore, once again, I have to support the essence of the 
wise comments delivered in this recent editorial. The statement 
“... Case reports and case series may be the ‘lowest’ or the ‘weakest’ 
level of evidence, but they often remain the ‘first line of evidence’ 
and is where everything begins…” holds, to me, true. What we 
need is a very strict peer-review process that ensures that high 
quality CR ultimately reach every journal’s readership.
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